Search

everythinglearnresearchcommunity

for

Search:↓

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Low levels of zinc and ferritin may be linked to the severity of alopecia areata in Iraqi patients.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Most patients with alopecia areata did not achieve lasting hair regrowth despite treatment.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Alopecia areata patients may have higher blood pressure and blood sugar, indicating a future risk of metabolic issues.

AC5 improves hair loss and hair quality with high satisfaction rates.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Patients were very satisfied with the multidisciplinary group visit for alopecia areata.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

High doses of dihydroartemisinin caused reversible liver toxicity in rats, with females more affected than males.

Low vitamin D levels are linked to Alopecia Areata.

Females with androgenic alopecia have significantly lower vitamin D3 and ferritin levels.

Adrenalin may help reduce hair fall and dandruff linked to stress in adventure sports enthusiasts.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Androgenetic alopecia is not linked to higher risks of hypertension or hyperaldosteronism.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

More lesions mean more severe alopecia areata.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Alopecia areata significantly impacts patients' mental health and quality of life.